Position in CDXS
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$151,723
+$67,932 QoQ
Shares Held
93,082
+81.1% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,920,327,422 across 248 Biotechnology names. CDXS ranks #204 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in CDXS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $151,723 | 93,082 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $83,791 | 51,406 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $4,018 | 1,647 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $70,059 | 28,713 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $108,858 | 40,468 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $229,780 | 48,172 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $108,212 | 35,134 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $77,661 | 25,052 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $112,328 | 32,186 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $147,665 | 48,415 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,781 | 2,001 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $74,566 | 26,631 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $163,364 | 39,460 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $126,494 | 27,145 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $162,025 | 26,737 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $359,635 | 34,382 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $761,990 | 36,954 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,316,622 | 42,105 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $1,179,536 | 50,711 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $2,656,271 | 117,223 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $3,451,673 | 150,794 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,055,435 | 48,348 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,866,036 | 158,947 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,025,266 | 177,655 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $243,254 | 21,797 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||